¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Multiple open wound of head"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • stab wound drain
    Âñ¸°»óó¹èÃâ°ü
  • secondary wound closure
    ÀÌÂ÷»óóºÀÇÕ
  • septic wound
    °¨¿°»óó, °¨¿°Ã¢
  • wound
    »óó
  • wound base
    »óó¹Ù´Ú, âÀú
  • wound closure
    »óó²ç¸É, »óóºÀÇÕ
  • wound contraction
    »óó¼öÃà, â»ó¼öÃà
  • wound excision
    »óóÀýÁ¦
  • wound healing
    »óóġÀ¯
  • wound infection
    »ó󰨿°
  • wound retractor
    »óó´ç±è±â
  • wound sepsis
    »óóÆÐÇ÷Áõ
  • wound strength
    â»ó°­µµ
  • wound tract
    »óó±æ, »çâ°ü, »çµµ
  • hereditary multiple exostosis
    À¯Àü´Ù¹ß»Àµ¹ÃâÁõ, À¯Àü´Ù¹ß¿Ü°ñÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • dehiscenced wound
    ¹ú¾îÁø»óó, ¿­°³Ã¢
  • stab wound drain
    Âñ¸°»óó¹èÃâ°ü
  • exit wound
    »çÃⱸ, ÀÚÃⱸ
  • wound entrance
    »çÀÔ±¸, ÀÚÀÔ±¸, »óóÀÔ±¸
  • wound excision
    »óóÀýÁ¦
  • firearms wound
    ȍ̢
  • gunshot wound
    ̄ȗ
  • hesitation wound
    ÁÖÀúÈç, ÁÖÀú»óó
  • wound healing
    »óóġÀ¯
  • impaling wound
    ÀÍâ
  • incised wound
    º¥»óó, Àýâ
  • wound infection
    »ó󰨿°
  • lacerated wound
    Âõ±ä»óó, ¿­Ã¢
  • penetrating wound
    °üÅëâ
  • puncture wound
    Âñ¸°»óó, ÀÚâ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • head of pancreas
    ÀÌÀÚ¸Ó¸®
  • head of pancreas
    ÃéµÎ(ÃéµÎ).
  • head of phalanges
    ¸¶µð»À¸Ó¸®
  • head of posterior horn
    µÚ»Ô¸Ó¸®
  • head of radius
    ¿ä°ñ¸Ó¸®, ¿ä°ñµÎ.
  • head of radius
    ³ë»À¸Ó¸®
  • head of radius
    ¿ä°ñ ¸Ó¸®, ¿ä°ñ µÎ(èúÍéÔé).
  • head of radius
    ¿ä°ñ¸Ó¸®, ¿ä°ñµÎ(èúÍéÔé).
  • head of rib
    ´Á°ñ¸Ó¸®, ´Á(×Î)°ñµÎ.
  • head of rib
    °¥ºñ»À¸Ó¸®
  • head of rib
    ´Á°ñ ¸Ó¸®, ´Á(×Î)°ñ µÎ.
  • head of stapes
    µî( )°ñµÎ.
  • head of stapes
    µîÀÚ»À¸Ó¸®
  • head of talus
    ¸ñ¸»°ñ¸Ó¸®, °Å°ñµÎ(ðëÍéÔé).
  • head of talus
    ¸ñ¸»»À¸Ó¸®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • repeated open application test
    ¹Ýº¹°³¹æµµÆ÷ °Ë»ç
  • aseptic wound
    ¹«±Õâ»ó.
  • bite wound
    ±³»ó.
  • bullet (splash) wound
    źâ(źâ), ÃÑâ(ÃÑâ).
  • contused wound
    Á»ó(Á»ó).
  • contused wound
    Á»ó(ñ©ß¿).
  • dissection wound
    ÀÌ´Üâ(ÀÌ´Üâ).
  • entrance of gunshot wound
    »çÀÔ±¸(»çÀÔ±¸).
  • festering wound
    ³óâ.
  • fire arms wound
    ȍ̢(ȍ̢).
  • gun shot wound
    ̢̄
  • gunshot wound
    ź»ó(ź»ó).
  • gutter wound
    ±¸Ã¢(±¸Ã¢).
  • handgun wound
    ±ÇÃÑ ÃÑâ
  • incised wound
    Àýâ(üâ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
WOX wound of exit
WX wound of exit
OHS Open Heart Surgery
OR   1) Operating Room; ¼ö¼ú½Ç
  2) Open Reduction
O/R Open Reduction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
OCP open circuit potential
OHS open heart surgery
ONTD open neural tube defect
ORF 2 open reading frame
ORF 2 open reading frame 2
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • open biopsy
    °³¹æ »ý°Ë, Àý°³ »ý°Ë, Á÷½ÃÇÏ »ý°Ë
    »ýüÀÇ ÀϺθ¦ °Ë»ç¸¦ À§ÇØ Ã¤ÃëÇÏ´Â ¹æ¹ý Áß ¼ö¼ú·Î äÃëÇÏ´Â ¹æ¹ýÀÌ´Ù. ¸ðµç Àå±â, Á¶Á÷ÀÌ ´ë»óÀÌ µÈ´Ù. ºñ¼ö¼úÀûÀÎ ¹æ¹ý¿¡ ºñÇØ, ¿Ü°úÀûÀ¸·Î ÀýÁ¦ ¸ñÀûÀ¸·Î ÇÏ´Â º´º¯À» ¼±ÅÃÇÒ ¼ö ÀÖ°í, ºñ±³Àû ÃæºÐ·®ÀÇ Ç¥º»À» ¾òÀ» ¼ö ÀÖ´Ù.
  • open bite
    °³±³ÇÕ, °³¹æ ±³ÇÕ
  • open cavity
    °³¹æ °øµ¿
  • open chain compound
    ¿­¸° »ç½½ È­ÇÕ¹°
  • open chest cardiac massage
    °³Èä½É ¸¶»çÁö, °³Èä½Ä ½É ¸¶»çÁö, °³Èä ½ÉÀå ¸¶»çÁö, °³Èä½Ä ½ÉÀå ¸¶»çÁö, °³Èä½É ¸¶»çÁö¹ý
  • open chest operation
    °³Èä ¼ö¼ú
  • open comedo
    °³¹æ ¸éÆ÷
  • open communication
    °³¹æµÈ ÀÇ»ç ¼ÒÅë
  • open door policy
    °³¹æ º´µ¿ ¹æÄ§
  • open drop
    °³¹æ Á¡Àû
  • open faced crown
    °³¸é ±Ý°ü
    ¼ø¸é, Çù¸é µî ±Ý¼Ó°üÀÇ ¿Ü°ü ºÎºÐÀ» °³Ã¢ÇÏ¿© ÀÚ¿¬ Ä¡¸éÀ» ³ëÃâ½ÃŲ Ä¡°ü º¸Ã¶. ÁÖ·Î ÀüÄ¡ºÎ¿¡ ¾²À̳ª Ä¡°æºÎÀÇ ÀûÇÕ ºÒ·®°ú ½É¹ÌÀûÀ¸·Î ÁÁÁö ¾ÊÀ¸¹Ç·Î ÀϹÝÀûÀ¸·Î »ç¿ëÀÌ ±Ý±âµÇ¾î ÀÖ´Ù. ÀüÄ¡ ¼øÃø Ä¡ÀººÎÀÇ Ä¡Á¶ µ¹±â°¡ ´ë´ÜÈ÷ Àüµ¹µÇ¾î À־ ÀÇÄ¡¿¡ ¼øÃø Ä¡ÀººÎ¸¦ ºÙÀÏ ¶§¿¡´Â ´õ¿í ±¸¼øÀÌ µ¹ÃâÇϰí, ¶Ç ´ëÈ­ ½Ã¿¡ Ä¡ÀººÎ°¡ ³ëÃâµÇ¾î ¿Ü°ü»ó º¸±â ÈäÇÒ ¶§ ÀÀ¿ëÇÏ´Â ÀÇÄ¡·Î¼­, ÀÇÄ¡ÀÇ ÀüÄ¡ºÎ Ä¡ÀºÀ» ¼ºÇüÇÏÁö ¾Ê°í ÀüÄ¡ ÀΰøÄ¡ÀÇ Ä¡°æºÎ¸¦ Á÷Á¢ ¸ðÇü»ó¿¡ »èÇÕÇÏ¿© ÀÇÄ¡»óÀÇ Á¦ ÀÏ ¼Ò±¸Ä¡ºÎ ÇùÃø Ä¡Àº º®À» ´ë»óÀ¸·Î ¾ÕÂÊ¿¡ ¿¬ÀåÇÏ¿© ±â°èÀûÀ¸·Î ÀÇÄ¡ÀÇ À¯Áö·ÂÀ» ÁÁ°Ô ÇÑ´Ù. ±¸°³ Á¡¸·ÀÌ °æ°íÇÏ¿© ÈíÂøÀÌ ¾çȣġ ¾ÊÀ» ¶§¿Í Ä¡Á¶Àå°æÀÌ ÂªÀ» °æ¿ì¿¡´Â ÇÏ¿©¼­´Â ¾È µÈ´Ù.
  • open fracture
    °³¹æ °ñÀý, °³¹æ¼º °ñÀý
    1. °ñÀÇ ÆÄ±«·Î ÀÎÇÑ ¿Ü»óÀÌ ÀÖ´Â °ÍÀ¸·Î º¹ÇÕ °ñÀýÀ̶ó°íµµ ÇÑ´Ù. 2. °ñÀýºÎ¿Í ÇǺÎÀÇ Ã¢»óÀÌ º¹ÇյǾî ÀÖ´Â À¯ÇüÀÇ °ñÀý. ¿ÜºÎÀÇ Èû¿¡ ÀÇÇØ ÇÇºÎ¿Í ¿¬Á¶Á÷¿¡ °³¹æ¼º ¼Õ»óÀ» ÀÏÀ¸Å°°í ÇÕÃļ­ ³»ºÎÀÇ °ñÀýÀ» ¼ö¹ÝÇÑ °æ¿ì³ª °ñÆíÀÇ ´ÜÆíÀÌ ³¯Ä«·Ó±â ¶§¹®¿¡ ¿¬Á¶Á÷À̳ª ÇǺθ¦ ¶Õ°í ¿ÜºÎ¿Í ÅëÇÏ´Â °æ¿ìµµ ÀÖ´Ù. °¨¿° ¹æÁö°¡ Áß¿äÇÏ´Ù.
  • open group
    °ø°³ Áý´Ü
  • open heart operation
    °³½É ¼ö¼ú
  • open heart surgical technique
    °³½É ¼ö¼ú ±â¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
multiple ego states Various psychological organizational state's reflecting different personas or life experiences.
(05 Mar 2000)
multiple embolism Embolism caused by the arrest of a number of small emboli.
(05 Mar 2000)
multiple endocrine adenomatosis The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance.
Synonym: multiple endocrine adenomatosis.
(05 Mar 2000)
multiple endocrine deficiency syndrome <syndrome> Acquired deficiency of the function of several endocrine glands, usually on an auto-immune basis.
Synonym: multiple glandular deficiency syndrome.
(05 Mar 2000)
multiple endocrine neoplasia (type I) This is a hereditary disorder in which two or more of the following glands: parathyroid, pancreas, pituitary, adrenals or thyroid develop hyperplasia or a tumour.
(type II) This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
Origin: Gr. Plassein = to form
(27 Sep 1997)
multiple endocrine neoplasia 1 <radiology> Multiple endrocrine neoplasia syndrome three P's.
Pituitary adenoma, 65% can develop Cushing's, acromegaly, prolactinoma, parathyroid hyperplasia / adenoma, 88% can develop hyper-PTH
pancreatic isleT-cell tumour, gastrinoma (Z-E) most common, 50% of Z-E can develop MEN-1, inconstant features: bronchial/intestinal carcinoid, thyroid adenoma, adrenal cortical tumour, lipoma, thymoma tissue expression
Primary hyperparathyroidism (90%), Gastrinoma (30%), Prolactinoma (15%), Other (10%).
Synonym: Wermer syndrome
(12 Dec 1998)
multiple endocrine neoplasia 2 <radiology> Multiple endocrine neoplasia syndrome, medullary thyroid carcinoma, usually multifocal; metastasis to local nodes, lung, liver, usually calcify in liver, pheochromocytoma, almost always bilateral, parathyroid hyperplasia, may be secondary to calcitonin secreted by medullary thyroid carcinoma inconstant feature: adrenal cortical hyperplasia
Synonym: Sipple syndrome
(12 Dec 1998)
multiple endocrine neoplasia 3 <radiology> Multiple endocrine neoplasia syndrome (type 2B, type 3), medullary thyroid carcinoma, pheochromocytoma, marfanoid habitus (Cf: Marfan syndrome), mucosal neuromas, neurofibromas, ganglioneuromatosis coli More info: MEN syndrome 2B
Synonym: Schimke, marfanoid syndrome
(12 Dec 1998)
multiple endocrine neoplasia type 1 A rare syndrome characterised by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to zollinger-ellison syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generally dependent on the genetic expression in individual patients.
(12 Dec 1998)
multiple endocrine neoplasia type 2 <syndrome> This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
(27 Sep 1997)
multiple endocrine neoplasia type 2a A type of multiple endocrine neoplasia characterised by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands.
(12 Dec 1998)
multiple endocrine neoplasia type 2b A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterised by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from men 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas.
(12 Dec 1998)
multiple epiphysial dysplasia A dominantly inherited abnormality of epiphyses characterised by difficulty in walking, pain and stiffness of joints, stubby fingers, and often dwarfism of short-limb type; on X-ray examination, the epiphyses are mottled and irregular; ossification centres are late in appearance and may be multiple, but the vertebrae are normal. There is also an autosomal recessive form .
Synonym: dysplasia epiphysialis multiplex.
(05 Mar 2000)
multiple exostosis A disturbance of enchondral bone growth in which multiple, generally benign osteochondromas of long bones appear during childhood, commonly with shortening of the radius and fibula; the ill-effects are usually mechanical but malignant change is rare; autosomal dominant inheritance.
Synonym: diaphysial aclasis, hereditary deforming chondrodystrophy, multiple exostosis, osteochondromatosis.
(05 Mar 2000)
multiple fission Division of the nucleus, simultaneously or successively, into a number of daughter nuclei, followed by division of the cell body into an equal number of parts, each containing a nucleus.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • head end
    (À¯¼± ÅÚ·¹ºñÁ¯ÀÇ)ÀüÆÄ Áß°è¼Ò
  • head fast
    À̹°ÀÇ ¹åÁÙ(¹è¸¦ ¸Å´Â)
  • head gate
    ¼ö¹®;Ãë¼ö¹®
  • head lamp
    =headlight
  • head linesman
    ¼±½É
  • head money
    Àεμ¼;(Æ÷·Î,¹üÀÎÀÇ Ã¼Æ÷ÇÑ ¼ö¿¡ µû¸¥)»ó±Ý
  • head note
    =head tone
  • head office
    º»»ç;º»Á¡
  • head register
    µÎ¼º ¼º¿ª
  • head resistance
    Àü¸é ÀúÇ×
  • head restaint
    (Ãæµ¹½Ã ¸ñ»À º¸È£¸¦ À§ÇÑ)Á¼® º£°³;¸Ó¸® ¹Þħ;Çìµå·¹½ºÆ®(headrest)
  • head scarf
    ¸Ó¸® ½ºÄ«ÇÁ
  • head sea
    ¿ª¶û;¸¶ÁÖÄ¡´Â ¹°°á
  • head shop
    ¸¶¾à º¹¿ë¿¡ °ü°è ÀÖ´Â ¹°°ÇÀ» ÆÄ´Â °¡°Ô
  • head shot
    ¾ó±¼ »çÁø
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á